• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Dizziness (2194); Malaise (2359)
Event Date 07/18/2018
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the ringer's lactate solution that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since 20-oct-2012.The customer has their own biomed who performs all the service for this instrument.Therakos did perform a system checkout procedure on this instrument on 6-nov-2017 during a software upgrade for this instrument.During this upgrade the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint categories, dizziness, malaise, and hypotension.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: dizziness, malaise, and hypotension.(b)(4).
 
Event Description
The customer called to report that a patient experienced dizziness, malaise, and hypotension during an extracorporeal photopheresis (ecp) treatment procedure.The customer stated that after 430 ml of whole blood processed, the patient complained of being dizzy and of not feeling well.The customer reported that the patient also developed hypotension with a blood pressure of 86/60.The customer stated that the patient was put in the trendelenburg position and 750 ml of ringer's lactate solution was administered to the patient.The customer reported that the patient then recovered and was in stable condition again.The customer stated that the patient's electrocardiogram was normal and that the patient's blood count showed no major changes.The customer reported that no further investigations were planned and that the patient was not admitted to the hospital.The customer stated that the patient then reported that she had not eaten that morning nor had she had anything to drink prior to the procedure.The patient's physician reported that the patient's lack of nutrition and their dehydration, directly caused the patient's symptoms.The customer stated that they were able to continue with the patient's treatment and that the treatment was successfully completed without any further problems.The customer reported that the treated cells were reinfused back to the patient.The patient's physician stated that the patient's ecp treatment contributed to the event; as the event was a concurrence of circumstances, one would not have happened without the other.The customer reported that the patient had tolerated their previous ecp treatments well.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key7770899
MDR Text Key116702375
Report Number2523595-2018-00134
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 08/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/18/2018
Initial Date FDA Received08/09/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/05/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
Patient Weight42
-
-